Bird & Bird advised the shareholders of Specim, Spectral Imaging in connection with the sale of their shares to Konica Minolta

We advised shareholders of Specim, Spectral Imaging Oy Ltd., a leading provider of hyperspectral imaging technology, in connection with their sale of all the shares in the company to Konica Minolta Inc. Specim is a Oulu-based Finnish technology company founded in 1995 and a leading player in hyperspectral imaging (HSI) market.

Bird & Bird's core team was led by partner Katia Ducker and our Corporate and Capital Markets specialist, Counsel Mika Puurunen.

"We have been very satisfied with Bird & Bird's outstanding advice and support through the whole transaction and negotiation process. They have left no stone unturned in always finding the best possible solution for all the sellers in the process", said board member Vilma Torstila, representative of the investor sellers in the process.

"This has been a demanding transaction with a global scale and thus we are very happy for the excellent result from the perspective of all the parties involved. This is a very good example of Bird & Bird's strong competence in the area of complex cross-border transaction processes, and we are very happy having had the opportunity to work with the sellers and the company to reach the best possible outcome", says lead partner Katia Duncker.

 

News & Deals

More News & Deals
Deal Bird & Bird advises Emaldo on strategic acquisition of CheckWatt, cementing Nordic leadership in renewable energy

May 28 2025

Read More
Deal Bird & Bird advises Eulero Capital on the acquisition of DIEWE Wheels

May 27 2025

Read More
News Bird & Bird ATMD Celebrates Double Victory at the 2025 Asian Legal Business Southeast Asia Law Awards

May 26 2025

Read More
Deal Bird & Bird advises Smart Digital Group as Singapore Counsel on Nasdaq Listing

May 22 2025

Read More
Deal Bird & Bird advises City & Guilds on sale of the Kineo group to Mind Tools

May 21 2025

Read More
News Bird & Bird opening office in Riyadh, Saudi Arabia

May 20 2025

Read More